Ariad Pharmaceuticals.Inc ARIA was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the …
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock is having a field day as rumors regarding a buyout continue to swirl. Japanese company Takeda Pharmaceutical Co Ltd is reportedly considering acquiring Ariad as part of a deal worth …
ARIAD stock surged 70+% on the news; Takeda posted a modest 6+% gain, and Valeant remained relatively unchanged. Investment Thesis(s) I) Valeant shareholders For Valeant shareholders, this news is moderately bad. I believe a Salix …
ARIAD Pharmaceuticals Inc.’s ARIA shares were up 12.5% with the company swinging to a profit in the second quarter of 2016. ARIAD reported second quarter 2016 earnings of 57 cents per share, far better than the Zacks Consensus …
High-flying biotech Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was called out for its rapid drug price raises today by Senator Bernie Sanders, and its stock quickly crashed as a result. Since the beginning of the year, the company …
StockConsultant.com - ARIA ($ARIA) Ariad Pharmaceuticals stock latest quote 10.67 +0.2,+1.9% has a new high breakout watch above 10.8. Full technical analysis and charts at http://chart.st/ARIA ARIA Stock Chart …
ARIAD Pharmaceuticals, Inc. ARIA remains focused on the discovery, development and commercialization of breakthrough treatments for cancer. This year was a tough one for the pharma sector, which had to grapple with media and political …
ARIAD Pharmaceuticals, Inc. ARIA is scheduled to report first-quarter 2016 results on May 10, before the opening bell. The company posted a negative earnings surprise of 14.29% in the fourth quarter of 2015. Let’s see how things are shaping …
The big news in the biotech sector this week is the acquisition agreement under which Japanese firm Takeda will be acquiring cancer-focused ARIAD ARIA for a whopping $5.2 billion. Several other licensing deals and agreements were …
Ariad Pharmaceuticals.Inc ARIA was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the …